Culwell Kelly 4/A
4/A · Evofem Biosciences, Inc. · Filed Dec 3, 2018
Insider Transaction Report
Form 4/AAmended
Culwell Kelly
Chief Medical Officer
Transactions
- Award
Common Stock
2018-11-28+100,000→ 100,000 totalExercise: $3.45Exp: 2028-11-28→ Common Stock (100,000 underlying)
Footnotes (2)
- [F1]The original Form 4, filed on November 29, 2018, is being amended to update the number of shares reported in Column 5(A) and Column 7 of Table II.
- [F2]The shares of common stock exercisable pursuant to the option will vest in a series of thirty-six (36) successive equal monthly installments upon completion of each additional month of service for the Issuer measured from November 28, 2018.